Glyburide Tablet
Product Images NDC 0093-8035

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 0093-8035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glyburide Tablet 1

FDA Label Image

Glyburide Tablet 2

FDA Label Image

Glyburide Tablet 3

Glyburide Tablet 3
This is a description of a medication, specifically Glipizide tablets USP in the dosage of 1.5 mg, and with lot number 361-32-734526240. The medication is packaged in a bottle with 100 tablets and the expiration date is not available.*
FDA Label Image

Glyburide Tablet 4

Glyburide Tablet 4
This is a medication bottle of Glyburide tablets with a strength of 3mg. The GTIN number (a type of global product identification code) is visible on the package. The label includes a warning to keep the medication out of the reach of children. The rest of the text seems to be a mix of non-English characters and symbols, making it difficult to make sense of it.*
FDA Label Image

Glyburide Tablet 5

Glyburide Tablet 5
This is a description of a medication named GlyBURIDE, which comes in the form of Tablets USP, with a strength of 6 mg. The medicine is produced by NDC and has a code of 0093-8036-01. The other details provided are the lot number of the tablets, which is 100, and the revision number, which is 06 for Rev. E produced in November 2017.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.